Interleukin-2 production in vitro: a new approach to the study of rabies vaccine immunogenicity as appraised by testing different glycoprotein presentations
- 31 July 1988
- journal article
- research article
- Published by Elsevier BV in Vaccine
- Vol. 6 (4), 331-338
- https://doi.org/10.1016/0264-410x(88)90179-x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Enhancement of antigen-specific interleukin 2 production by adding liposomes to rabies antigens for primingImmunology Letters, 1988
- The association of the rabies glycoprotein with liposome (immunosome) induces an in vitro specific release of interleukin 2Cellular Immunology, 1987
- The influence of the type of immunosorbent on rabies antibody EIA; advantages of purified glycoprotein over whole virusJournal of Biological Standardization, 1986
- A rapid rabies enzyme immuno-diagnosis (RREID): a useful and simple technique for the routine diagnosis of rabiesJournal of Biological Standardization, 1986
- Stimulation of cytotoxic T-lymphocyte responses by rabies virus glycoprotein and identification of an immunodominant domainMolecular Immunology, 1986
- Use of a monoclonal antibody for quantitation of rabies vaccine glycoprotein by enzyme immunoassayJournal of Biological Standardization, 1985
- Rabies Subunit VaccinesJournal of General Virology, 1983
- Acute rabies death mediated by antibodyNature, 1981
- A Model in Mice for the Study of the Early Death Phenomenon after Vaccination and Challenge with Rabies VirusJournal of General Virology, 1980
- Viral Subunits for Rabies VaccinationNature, 1969